---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-146874"
form_type: "8-K"
ticker: "ELVN"
cik: "0001672619"
company_name: "Enliven Therapeutics, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:31:41.623099+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Enliven Therapeutics stockholders elect three Class II directors, ratify Deloitte as auditor at 2025 annual meeting

## Summary
- Elected Class II directors: Rahul D. Ballal (36,870,420 for), Jake Bauer (37,250,826 for), Andrew Phillips (31,957,928 for).
- Ratified Deloitte & Touche LLP as independent auditor for FY2025 (45,392,647 for, 2,435 against, 35,215 abstain).
- Broker non-votes of 8,099,804 existed for director elections; ratification had no broker non-votes.

## SEC filing metadata
- accession: 0001193125-25-146874
- form_type: 8-K
- ticker: ELVN
- cik: 0001672619
- company_name: Enliven Therapeutics, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672619/000119312525146874/0001193125-25-146874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672619/000119312525146874/d80015d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-146874
- JSON: https://secwatch.observer/filing/0001193125-25-146874.json
- Plain text: https://secwatch.observer/filing/0001193125-25-146874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.